Gene · 50652
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study. | J Transl Med | 2023 | 37821919 | PubTator, text mining | PubMed |
| Advancing Healthcare: Synergizing Biosensors and Machine Learning for Early Cancer Diagnosis. | Biosensors (Basel) | 2023 | 37754118 | PubTator, text mining | PubMed |
| Impact of modifiable lifestyle risk factors for prostate cancer prevention: a review of the literature. | Front Oncol | 2023 | 37746271 | PubTator, text mining | PubMed |
| Recent advances and future perspectives in the therapeutics of prostate cancer. | Exp Hematol Oncol | 2023 | 37740236 | PubTator, text mining | PubMed |
| Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37735632 | PubTator, text mining | PubMed |
| Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool. | Front Oncol | 2023 | 37692852 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Aggressive Prostate Cancer in Patients Treated with Active Surveillance. | Cancers (Basel) | 2023 | 37686546 | PubTator, text mining | PubMed |
| Can Genetic Markers Predict the Sporadic Form of Alzheimer's Disease? An Updated Review on Genetic Peripheral Markers. | Int J Mol Sci | 2023 | 37686283 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Neurodegenerative Diseases: An Update. | Int J Mol Sci | 2023 | 37685965 | PubTator, text mining | PubMed |
| The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applications. | Front Pharmacol | 2023 | 37670949 | PubTator, text mining | PubMed |
| Long non‑coding RNAs, lipid metabolism and cancer (Review). | Exp Ther Med | 2023 | 37664674 | PubTator, text mining | PubMed |
| The diagnostic effectiveness of serum sialic acid predicts both qualitative and quantitative prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/mL. | Front Endocrinol (Lausanne) | 2023 | 37645415 | PubTator, text mining | PubMed |
| Revealing metastatic castration-resistant prostate cancer master regulator through lncRNAs-centered regulatory network. | Cancer Med | 2023 | 37644825 | PubTator, text mining | PubMed |
| H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients. | Cancer Genomics Proteomics | 2023 | 37643783 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders. | Int J Mol Sci | 2023 | 37628760 | PubTator, text mining | PubMed |
| Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2023 | 37627171 | PubTator, text mining | PubMed |
| The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach. | Cancers (Basel) | 2023 | 37627055 | PubTator, text mining | PubMed |
| Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors. | Cancer Res | 2023 | 37584517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50652/papers?page=8